IMMP vs IMRX

Immutep Limited vs Immuneering Corporation — Valuation Comparison 2026

IMMP

Biotechnology
Immutep Limited
Quality
4.9
out of 10
Value Trap
24
SAFE
Price
$0.44
Last close
Models
9/13
Active
VS

IMRX

Biotechnology
Immuneering Corporation
Quality
4.5
out of 10
Value Trap
26
LOW
Price
$5.06
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType IMMP Fair ValueIMMP Upside IMRX Fair ValueIMRX Upside
Bayesian DCF Intrinsic $0.30 -33.5% $1.74 -65.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.01 -98.3% $1.66 -67.2%
Dynamic NAV Asset-Based $0.68 +52.4% $2.65 -47.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMMP vs IMRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMMP vs IMRX — Which Stock Is More Undervalued?

IMMP scores higher with a 4.9/10 quality rating vs IMRX's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Immutep Limited (IMMP) and Immuneering Corporation (IMRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMMP currently trades at $0.44 with a QOC of 4.9/10, while IMRX trades at $5.06 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).